U.S. Physical Therapy, Inc. (USPH)
- Previous Close
106.25 - Open
106.54 - Bid 102.90 x 1000
- Ask 113.00 x 1000
- Day's Range
105.39 - 106.75 - 52 Week Range
78.08 - 124.11 - Volume
43,247 - Avg. Volume
71,314 - Market Cap (intraday)
1.608B - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
92.00 - EPS (TTM)
1.16 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield 1.76 (1.65%)
- Ex-Dividend Date May 22, 2024
- 1y Target Est
121.38
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
www.usph.com3,899
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: USPH
Performance Overview: USPH
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USPH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USPH
Valuation Measures
Market Cap
1.61B
Enterprise Value
1.73B
Trailing P/E
92.00
Forward P/E
39.37
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.56
Price/Book (mrq)
3.35
Enterprise Value/Revenue
2.83
Enterprise Value/EBITDA
23.27
Financial Highlights
Profitability and Income Statement
Profit Margin
4.77%
Return on Assets (ttm)
4.43%
Return on Equity (ttm)
6.47%
Revenue (ttm)
605.68M
Net Income Avi to Common (ttm)
17.62M
Diluted EPS (ttm)
1.16
Balance Sheet and Cash Flow
Total Cash (mrq)
135.27M
Total Debt/Equity (mrq)
38.15%
Levered Free Cash Flow (ttm)
56.99M
Research Analysis: USPH
Company Insights: USPH
USPH does not have Company Insights